Literature DB >> 8320309

Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

T Y Ling1, T J Sims, H A Chen, C W Whitney, B J Moncla, L D Engel, R C Page.   

Abstract

Most patients with localized juvenile periodontitis (LJP) manifest serum IgG antibodies specifically reactive with antigens of Actinobacillus actinomycetemcomitans serotype b (Aa-b). Whether these antibodies are protective, destructive, or irrelevant to the progress of the disease remains unclear. We report results of studies aimed at assessing the subclass IgG responses in 35 LJP patients and 35 periodontally normal control subjects using well-characterized monoclonal antibody subclass reagents in an enzyme-linked immunosorbent assay. Our data show that the mean value for total IgG reactive with antigens of Aa-b was more than sevenfold higher for patients than for normal control sera (2349.6 micrograms/ml for patients vs 332.2 micrograms/ml for controls). Individual patients and control subjects were classified as high- or low-titer, using twice the median value for total anti-Aa-b IgG in control sera as the cutoff. Of 35 patients, 26 (74%) were high-titer, and 9 (26%) were low-titer. This compares to 5 normal control subjects (14%) high-titer and 30 (86%) low-titer. IgG2 accounted for the major quantitative response in both patients and control subjects. Indeed, the mean IgG2 values for both concentration and percentage of total specific IgG were greater than the combined values for specific anti-Aa-b IgG1, IgG3, and IgG4. Of the 26 high-titer sera, IgG2 predominated in 24, with IgG1 and IgG3 predominating in 1 each; IgG2 predominated in only 2 of the low-titer sera.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320309     DOI: 10.1007/bf00919266

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  P J Baker; M E Wilson
Journal:  Oral Microbiol Immunol       Date:  1989-06

Review 2.  IgG subclass changes in response to vaccination.

Authors:  L Hammarström; C I Smith
Journal:  Monogr Allergy       Date:  1986

3.  Effects of race and periodontal status on antibody reactive with Actinobacillus actinomycetemcomitans strain Y4.

Authors:  J C Gunsolley; J G Tew; C M Gooss; J A Burmeister; H A Schenkein
Journal:  J Periodontal Res       Date:  1988-09       Impact factor: 4.419

4.  Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide.

Authors:  M E Wilson; R G Hamilton
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  The immunodominant outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype-specific high-molecular-mass carbohydrate moiety of lipopolysaccharide.

Authors:  R C Page; T J Sims; L D Engel; B J Moncla; B Bainbridge; J Stray; R P Darveau
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Antigens of Actinobacillus actinomycetemcomitans identified by immunoblotting with sera from patients with localized human juvenile periodontitis and generalized severe periodontitis.

Authors:  H Watanabe; P D Marsh; L Ivanyi
Journal:  Arch Oral Biol       Date:  1989       Impact factor: 2.633

7.  Antigens of Actinobacillus actinomycetemcomitans recognized by patients with juvenile periodontitis and periodontally normal subjects.

Authors:  T J Sims; B J Moncla; R P Darveau; R C Page
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

8.  IgG and IgG subclasses in human periodontosis (juvenile periodontitis). Serum concentrations.

Authors:  T C Waldrop; B F Mackler; P Schur
Journal:  J Periodontol       Date:  1981-02       Impact factor: 6.993

9.  Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families.

Authors:  J J Zambon; L A Christersson; J Slots
Journal:  J Periodontol       Date:  1983-12       Impact factor: 6.993

10.  Clinical and microbiological evaluation of therapy for juvenile periodontitis.

Authors:  K S Kornman; P B Robertson
Journal:  J Periodontol       Date:  1985-08       Impact factor: 6.993

View more
  5 in total

1.  Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis.

Authors:  Tiina Vilkuna-Rautiainen; Pirkko J Pussinen; Kimmo Mattila; Marja Vesanen; Heidi Ahman; Başak Doğan; Sirkka Asikainen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Heterogeneity of antibodies reactive with the dominant antigen of Actinobacillus actinomycetemcomitans.

Authors:  K Nakashima; H A Schenkein; J V Califano; J G Tew
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  Avidity of antibody responses to Actinobacillus actinomycetemcomitans in periodontitis.

Authors:  D S O'Dell; J L Ebersole
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

4.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals.

Authors:  H Lu; M Wang; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates.

Authors:  G R Persson; D Engel; C Whitney; R Darveau; A Weinberg; M Brunsvold; R C Page
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.